Rebuilding Trust in Healthcare With the ABIM Foundation

Atezolizumab or durvalumab, combined with platinum-doublet regimens, delivered superior responses and survival in patients often excluded from clinical trials.

On this episode of Managed Care Cast, experts discuss the practical implications of bias in electronic health care records.

High-risk patients who cannot find a matched sibling or matched unrelated donor may achieve a similar benefit from a haploidentical donor.

On this episode of Managed Care Cast, experts discuss behavioral health services, stigma reduction, and the 4 dimensions of recovery.

The study confirms that biologics are highly effective in real-world HS management, and highlights the need for a comprehensive treatment strategy considering both skin symptoms and systemic health.

Multidisciplinary care influenced therapy choices but did not substantially shorten treatment delays for patients with sarcoma.